Want to see AVTR full AI Analyst Report?
AVTR Stock Chart & Stats
$11.76
$0.32(2.80%)
At close: 4:00 PM EDT
$11.76
$0.32(2.80%)
Day’s Range― - ―
52-Week Range$7.27 - $15.93
Previous CloseN/A
Volume16.50M
Average Volume (3M)8.85M
Market Cap
$7.81B
Enterprise Value$8.84K
Total Cash (Recent Filing)$279.30M
Total Debt (Recent Filing)$3.82B
Price to Earnings (P/E)―
Beta0.85
Next Earnings
Jul 29, 2026EPS Estimate
0.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.80
Shares Outstanding682,755,430
10 Day Avg. Volume10,970,589
30 Day Avg. Volume8,850,736
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)1.40
Price to Sales (P/S)1.19
P/FCF Ratio15.70
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$9.22Price Target Upside-21.58% Downside
Rating ConsensusHold
Number of Analyst Covering10
EPS Forecast (FY)0.79
Revenue Forecast (FY)$6.50B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow GenerationAvantor’s material operating and free cash flow despite reported net losses indicates durable cash conversion from operations. That liquidity underpins debt reduction, funds targeted CapEx/automation and supports the company through a multi-quarter revenue trough, increasing resilience during a 2–6 month recovery period.
Improved Leverage And Balance-sheet StabilityA materially lower debt-to-equity ratio reflects meaningful deleveraging and a more stable capital structure. Reduced leverage enhances financial flexibility to invest in efficiency, absorb near-term profit weakness, and pursue the stated priority of getting sustainably below target leverage, lowering default and refinancing risks.
Recurring, Embedded Demand From Regulated Life-science CustomersAvantor’s revenue is anchored in high-frequency consumables and regulated bioprocess workflows, where customer qualification and integration create switching costs. These embedded, repeat-demand economics and bundled services (logistics/onsite) support predictable baseline demand and higher customer retention over months.
Bears Say
Sharp Revenue Decline And Return To LossesA steep TTM revenue decline and reversion to negative net margins erode scale economics and operating leverage. Sustained top-line weakness reduces pricing power and investment capacity, heightens the risk that restructuring and efficiency projects won’t offset losses within a 2–6 month horizon, pressuring recovery prospects.
Ongoing Margin Pressure From Mix, Freight And InflationPersistent mix shifts, elevated freight and raw-material inflation create structural margin headwinds that can erode profitability even as volumes stabilize. These cost pressures are multi-quarter in nature and may blunt the benefits of operational efficiency until pricing or input-cost dynamics normalize.
Execution Risk From Leadership TransitionA CFO departure amid a turnaround raises near-term execution risk on debt reduction, cash targets and Revival program delivery. Leadership changes can slow financial reporting, capital-allocation decisions and stakeholder confidence, complicating execution of structural fixes over the next several months.
Avantor News
AVTR FAQ
What was Avantor Inc’s price range in the past 12 months?
Avantor Inc lowest stock price was $7.26 and its highest was $15.93 in the past 12 months.
What is Avantor Inc’s market cap?
Avantor Inc’s market cap is $7.81B.
When is Avantor Inc’s upcoming earnings report date?
Avantor Inc’s upcoming earnings report date is Jul 29, 2026 which is today.
How were Avantor Inc’s earnings last quarter?
Currently, no data Available
Is Avantor Inc overvalued?
According to Wall Street analysts Avantor Inc’s price is currently Overvalued.
Does Avantor Inc pay dividends?
Avantor Inc does not currently pay dividends.
What is Avantor Inc’s EPS estimate?
Avantor Inc’s EPS estimate is 0.19.
How many shares outstanding does Avantor Inc have?
Avantor Inc has 682,755,430 shares outstanding.
What happened to Avantor Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Avantor Inc?
Currently, no hedge funds are holding shares in AVTR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Avantor Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$9.22 (-21.58% Downside)
$9.22 (-21.58% Downside)
Blogger Sentiment
Neutral
AVTR Sentiment 100%
Sector Average 65%
Sector Average 65%
Hedge Fund Trend
Increased
By 17.7M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $286.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 1.1%
Last 30 Days ▲ 1.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-18.34%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-5.38%
Trailing 12-Months
Company Description
Avantor Inc
Avantor, Inc. (AVTR) is a global provider of mission-critical products and services for customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials markets. The company supplies a broad portfolio of materials and consumables (including chemicals, reagents, lab supplies, and single-use components), equipment, and services that support research, development, and manufacturing workflows, with a strong emphasis on regulated life-science and bioprocessing applications.
AVTR Company Deck
AVTR Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced picture: clear operational progress from the Revival program (leadership refresh, digital and kaizen-driven efficiency projects, improved BMP order trends and e-commerce gains) and a Q1 outperformance on EPS versus expectations. However, meaningful near-term revenue declines, margin pressure from mix and freight, customer prebates depressing early cash flow, geopolitical inflationary risk ($10–$20M headwind) and a CFO transition temper the outlook. Management reaffirmed guidance and expects stabilization in H1 with a path to organic growth in H2, but execution and macro risks will determine whether that recovery materializes.View all AVTR earnings summariesAVTR Net sales Breakdown
58.44% Americas
34.74% Europe
6.82% AMEA
AVTR Stock 12 Month Forecast
Average Price Target
$9.22
▼(-21.58% Downside)
Technical Analysis
Albemarle
―
Eastman Chemical
―
Quaker Chemical
―
Sociedad Quimica Y Minera SA
―
Westlake Corporation
―
Ownership Overview
0.67% Insiders
40.52% Mutual Funds
1.58% Other Institutional Investors
38.79% Public Companies and
Individual Investors